liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting
AstraZeneca Nordic-Baltic, Södertälje, Sweden..
AstraZeneca Nordic-Baltic, Södertälje, Sweden..
Uppsala University, Uppsala, Sweden..
Linköping University, Department of Medical and Health Sciences, Division of Community Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Local Health Care Services in West Östergötland, "Primary Health Care in Motala".
Show others and affiliations
2015 (English)In: Primary Care Diabetes, ISSN 1751-9918, E-ISSN 1878-0210, Vol. 9, no 5, 330-337 p.Article in journal (Refereed) Published
Abstract [en]

Aims: To describe healthcare resource use patterns and estimate healthcare costs of newly diagnosed Type 2 diabetes mellitus (T2DM) patients in Sweden. Methods: Patients with a newly diagnosed T2DM between 1999 and 2009 were identified from 84 Swedish primary care centres. Healthcare resource use data, excluding pharmaceuticals, were extracted from electronic patient records and a national patient register, and reported as per patient mean number of primary care contacts, laboratory tests and hospitalizations. Per patient mean healthcare costs are reported as annual and cumulative costs. Results: During a median (maximum) of 4.6 (9.0) years follow-up; 38,956 patients (183,513 patient years) on average made 81 primary care contacts, was hospitalized 2.14 times, and took 31 laboratory tests. Mean per patient annual healthcare costs were (sic)4128 (95% CI, 4054-4199) the first year after diagnosis, (sic)2708 (95% CI, 2641-2776) the second year, and (sic)3030 (95% CI, 2854-3204) in year 9 (2012 values). Mean per patient cumulative healthcare costs were (sic)26,503 (95% CI, 26,025-26,970) at 9 years of follow-up. Hospitalizations accounted for the majority of healthcare costs. Conclusions: Although newly diagnosed T2DM patients require a substantial amount of healthcare services in primary care, hospitalizations account for the majority of healthcare costs. (C) 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
ELSEVIER SCI LTD , 2015. Vol. 9, no 5, 330-337 p.
Keyword [en]
Type 2 diabetes mellitus; Healthcare utilization; Healthcare costs; Retrospective observational study
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:liu:diva-122105DOI: 10.1016/j.pcd.2015.01.001ISI: 000361868100002PubMedID: 25631469OAI: oai:DiVA.org:liu-122105DiVA: diva2:861887
Note

Funding Agencies|AstraZeneca

Available from: 2015-10-19 Created: 2015-10-19 Last updated: 2016-03-31

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Östgren, Carl johanHenriksson, Martin
By organisation
Division of Community MedicineFaculty of Medicine and Health Sciences"Primary Health Care in Motala"
In the same journal
Primary Care Diabetes
Health Care Service and Management, Health Policy and Services and Health Economy

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 75 hits
ReferencesLink to record
Permanent link

Direct link